Ophthalmic Case Studies and Novel Approach


In a small randomized controlled trial, production of aqueous tears and secretion of goblet cells increased following application of the Occleve Intranasal Lacrimal Neurostimulator (Allergan).This handheld device works by delivering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve in the nasal cavities. It potentially offers a new mechanism for treating dry organ of sight disease—now largely managed with artificial tears and anti-inflammatory agents.


    Related Conference of Ophthalmic Case Studies and Novel Approach

    February 17-18, 2025

    11th Global Ophthalmology Meeting

    Amsterdam, Netherlands
    February 24-25, 2025

    9th World Congress on Eye and Vision

    Madrid, Spain
    March 17-18, 2025

    39th European Ophthalmology Congress

    Berlin, Germany
    April 07-08, 2025

    6th World congress on Ophthalmology and Optometry

    Amsterdam, Netherlands
    April 29-30, 2025

    35th International Congress on Vision Science and Eye

    Barcelona, Spain
    April 29-30, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    June 12-13, 2025

    6th International Conference on Ophthalmology and Optometry

    London, UK
    June 12-13, 2025

    6th International Conference on Optometry

    London, UK
    June 17-18, 2025

    25th Global Ophthalmologists Annual Meeting

    Copenhagen, Denmark
    July 07-08, 2025

    9th International Conference & Expo on Euro Optometry and Vision Science

    Zurich, Switzerland
    July 28-29, 2025

    10th International Conference on Eye and Vision

    Dubai, UAE

    Ophthalmic Case Studies and Novel Approach Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in